Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: ANTINEOPLASTIC AGENTS, HORMONAL - THERAPEUTIC USE , . Treffer: 29

2019

Filipits, M; Dubsky, P; Rudas, M; Greil, R; Balic, M; Bago-Horvath, Z; Singer, CF; Hlauschek, D; Brown, K; Bernhisel, R; Kronenwett, R; Lancaster, JM; Fitzal, F; Gnant, M Prediction of Distant Recurrence Using EndoPredict Among Women with ER⁺, HER2^- Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only.
Clin Cancer Res. 2019; 25(13):3865-3872 Doi: 10.1158/1078-0432.CCR-19-0376 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Abdollah, F; Sammon, JD; Reznor, G; Sood, A; Schmid, M; Klett, DE; Sun, M; Aizer, AA; Choueiri, TK; Hu, JC; Kim, SP; Kibel, AS; Nguyen, PL; Menon, M; Trinh, QD Medical androgen deprivation therapy and increased non-cancer mortality in non-metastatic prostate cancer patients aged ≥66 years.
Eur J Surg Oncol. 2015; 41(11):1529-39 Doi: 10.1016/j.ejso.2015.06.011
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Sestak, I; Filipits, M; Dowsett, M; Balic, M; Lopez-Knowles, E; Greil, R; Dubsky, P; Stoeger, H; Rudas, M; Jakesz, R; Ferree, S; Cowens, JW; Nielsen, T; Schaper, C; Fesl, C; Cuzick, J Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Ann Oncol. 2015; 26(8):1685-1691 Doi: 10.1093/annonc/mdv215 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Filipits, M; Nielsen, TO; Rudas, M; Greil, R; Stöger, H; Jakesz, R; Bago-Horvath, Z; Dietze, O; Regitnig, P; Gruber-Rossipal, C; Müller-Holzner, E; Singer, CF; Mlineritsch, B; Dubsky, P; Bauernhofer, T; Hubalek, M; Knauer, M; Trapl, H; Fesl, C; Schaper, C; Ferree, S; Liu, S; Cowens, JW; Gnant, M; Austrian Breast and Colorectal Cancer Study Group The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.
Clin Cancer Res. 2014; 20(5):1298-1305 Doi: 10.1158/1078-0432.CCR-13-1845 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Filipits, M; Greil, R; Stoeger, H; Rudas, M; Bago-Horvath, Z; Mlineritsch, B; Kwasny, W; Knauer, M; Singer, C; Jakesz, R; Dubsky, P; Fitzal, F; Bartsch, R; Steger, G; Balic, M; Ressler, S; Cowens, JW; Storhoff, J; Ferree, S; Schaper, C; Liu, S; Fesl, C; Nielsen, TO; Austrian Breast and Colorectal Cancer Study Group Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Ann Oncol. 2014; 25(2):339-345 Doi: 10.1093/annonc/mdt494 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hopfinger, G; Nösslinger, T; Lang, A; Linkesch, W; Melchardt, T; Weiss, L; Egle, A; Greil, R Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.
Ann Hematol. 2014; 93(3):459-462 Doi: 10.1007/s00277-014-2009-0
Web of Science PubMed FullText FullText_MUG

 

Kluth, LA; Shariat, SF; Kratzik, C; Tagawa, S; Sonpavde, G; Rieken, M; Scherr, DS; Pummer, K The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapy.
World J Urol. 2014; 32(3):669-676 Doi: 10.1007/s00345-013-1157-5
Web of Science PubMed FullText FullText_MUG

 

Luschin, G; Habersack, M Oral information about side effects of endocrine therapy for early breast cancer patients at initial consultation and first follow-up visit: an online survey.
Health Commun. 2014; 29(4):421-426 Doi: 10.1080/10410236.2012.743096
Web of Science PubMed FullText FullText_MUG

 

Province, MA; Goetz, MP; Brauch, H; Flockhart, DA; Hebert, JM; Whaley, R; Suman, VJ; Schroth, W; Winter, S; Zembutsu, H; Mushiroda, T; Newman, WG; Lee, MT; Ambrosone, CB; Beckmann, MW; Choi, JY; Dieudonné, AS; Fasching, PA; Ferraldeschi, R; Gong, L; Haschke-Becher, E; Howell, A; Jordan, LB; Hamann, U; Kiyotani, K; Krippl, P; Lambrechts, D; Latif, A; Langsenlehner, U; Lorizio, W; Neven, P; Nguyen, AT; Park, BW; Purdie, CA; Quinlan, P; Renner, W; Schmidt, M; Schwab, M; Shin, JG; Stingl, JC; Wegman, P; Wingren, S; Wu, AH; Ziv, E; Zirpoli, G; Thompson, AM; Jordan, VC; Nakamura, Y; Altman, RB; Ames, MM; Weinshilboum, RM; Eichelbaum, M; Ingle, JN; Klein, TE; International Tamoxifen Pharmacogenomics Consortium CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.
Clin Pharmacol Ther. 2014; 95(2):216-227 Doi: 10.1038/clpt.2013.186 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Pfeiler, G; Stöger, H; Dubsky, P; Mlineritsch, B; Singer, C; Balic, M; Fitzal, F; Moik, M; Kwasny, W; Selim, U; Renner, K; Ploner, F; Steger, GG; Seifert, M; Hofbauer, F; Sandbichler, P; Samonigg, H; Jakesz, R; Greil, R; Fesl, C; Gnant, M; ABCSG Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
Br J Cancer. 2013; 108(7):1408-1414 Doi: 10.1038/bjc.2013.114 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Santos, M; Nogueira, L; Talahri, C; Massone, C; Cerroni, L; Mira, MT; Talhari, S Hydroa vacciniforme-like lymphoma in a patient from the Brazilian Amazon.
Int J Dermatol. 2013; 52(5): 641-643. Doi: 10.1111/j.1365-4632.2011.05097.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2012

Lee, DJ; Cha, EK; Dubin, JM; Beltran, H; Chromecki, TF; Fajkovic, H; Scherr, DS; Tagawa, ST; Shariat, SF Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).
BJU Int. 2012; 109(7): 968-985. Doi: 10.1111/j.1464-410X.2011.10643.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Heck, D; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Pristauz, G; Bauernhofer, T; Eidtmann, H; Eiermann, W; Steger, G; Kwasny, W; Dubsky, P; Hochreiner, G; Forsthuber, EP; Fesl, C; Greil, R; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Lancet Oncol. 2011; 12(7):631-641 Doi: 10.1016/S1470-2045(11)70122-X
Web of Science PubMed FullText FullText_MUG

 

Pfeiler, G; Königsberg, R; Fesl, C; Mlineritsch, B; Stoeger, H; Singer, CF; Pöstlberger, S; Steger, GG; Seifert, M; Dubsky, P; Taucher, S; Samonigg, H; Bjelic-Radisic, V; Greil, R; Marth, C; Gnant, M Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial.
J Clin Oncol. 2011; 29(19):2653-2659 Doi: 10.1200/JCO.2010.33.2585 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2010

Stingl, JC; Parmar, S; Huber-Wechselberger, A; Kainz, A; Renner, W; Seeringer, A; Brockmöller, J; Langsenlehner, U; Krippl, P; Haschke-Becher, E Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment.
Curr Med Res Opin. 2010; 26(11):2535-2542 Doi: 10.1185/03007995.2010.518304
Web of Science PubMed FullText FullText_MUG

 

Symmans, WF; Hatzis, C; Sotiriou, C; Andre, F; Peintinger, F; Regitnig, P; Daxenbichler, G; Desmedt, C; Domont, J; Marth, C; Delaloge, S; Bauernhofer, T; Valero, V; Booser, DJ; Hortobagyi, GN; Pusztai, L Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer.
J Clin Oncol. 2010; 28(27): 4111-4119. Doi: 10.1200/JCO.2010.28.4273 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Filipits, M; Rudas, M; Heinzl, H; Jakesz, R; Kubista, E; Lax, S; Schippinger, W; Dietze, O; Greil, R; Stiglbauer, W; Kwasny, W; Nader, A; Stierer, M; Gnant, MF; Austrian Breast and Colorectal Cancer Study Group Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.
Clin Cancer Res. 2009; 15(18):5888-5894 Doi: 10.1158/1078-0432.CCR-09-0728 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Pöstlberger, S; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Bjelic-Radisic, V; Samonigg, H; Tausch, C; Eidtmann, H; Steger, G; Kwasny, W; Dubsky, P; Fridrik, M; Fitzal, F; Stierer, M; Rücklinger, E; Greil, R; ABCSG-12 Trial Investigators; Marth, C Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
N Engl J Med. 2009; 360(7):679-691 Doi: 10.1056/NEJMoa0806285 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Pötter, R; Gnant, M; Kwasny, W; Tausch, C; Handl-Zeller, L; Pakisch, B; Taucher, S; Hammer, J; Luschin-Ebengreuth, G; Schmid, M; Sedlmayer, F; Stierer, M; Reiner, G; Kapp, K; Hofbauer, F; Rottenfusser, A; Pöstlberger, S; Haider, K; Draxler, W; Jakesz, R; Austrian Breast and Colorectal Cancer Study Group Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
INT J RADIAT ONCOL BIOL PHYS. 2007; 68(2): 334-340. Doi: 10.1016/j.ijrobp.2006.12.045
Web of Science PubMed FullText FullText_MUG

 

Reich, O; Regauer, S Hormonal therapy of endometrial stromal sarcoma.
Curr Opin Oncol. 2007; 19(4):347-352 Doi: 10.1097/CCO.0b013e3281a7ef3a
Web of Science PubMed FullText FullText_MUG

 

2006

Reich, O; Regauer, S Survey of adjuvant hormone therapy in patients after endometrial stromal sarcoma.
Eur J Gynaecol Oncol. 2006; 27(2):150-152
Web of Science PubMed

 

2005

Filipits, M; Pohl, G; Rudas, M; Dietze, O; Lax, S; Grill, R; Pirker, R; Zielinski, CC; Hausmaninger, H; Kubista, E; Samonigg, H; Jakesz, R Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group.
J Clin Oncol. 2005; 23(6):1161-1168 Doi: 10.1200/JCO.2005.03.033 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Reich, O; Regauer, S Is tamoxifen an option for patients with endometrial stromal sarcoma?
Gynecol Oncol. 2005; 96(2):561; author reply 561-561; author reply 561 Doi: 10.1016/j.ygyno.2004.11.003
Web of Science PubMed FullText FullText_MUG

 

2004

Reich, O; Regauer, S Aromatase expression in low-grade endometrial stromal sarcomas: an immunohistochemical study.
Mod Pathol. 2004; 17(1):104-108 Doi: 10.1038/sj.modpathol.3800031 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2003

Mayer, R; Pummer, K; Quehenberger, F; Mayer, E; Feigl, G; Langsenlehner, U; Hackl, A Analysis of competing risk parameters in irradiated prostate cancer patients.
Strahlenther Onkol. 2003; 179(7):452-457 Doi: 10.1007/s00066-003-1058-4
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Jakesz, R; Hausmaninger, H; Samonigg, H Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer.
Eur J Cancer. 2002; 38(3):327-332 Doi: 10.1016%2FS0959-8049%2801%2900375-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1999

Pummer, K; Schmid, H; Trummer, H; Augustin, H; Hubmer, G Hormonal therapy of prostate cancer: is there any news?
Urol Int. 1999; 63(1):80-85 Doi: 10.1159/000030422
Web of Science PubMed FullText FullText_MUG

 

1998

Jakesz, R; Hausmaninger, H; Samonigg, H; Kubista, E; Haider, K; Mlineritsch, B; Schmid, M; Tausch, C; Reiner, G; Renner, K; Stierer, M; Jatzko, G; Hofbauer, F; Fridrik, M; Schennach, W; Sevelda, P; Dadak, C; Haid, A; Scholz, R; Lenzhofer, P; Steindorfer, P; Berger, A; Mischinger, HJ Therapy studies of the Austrian Breast Cancer Group (ABC).
Zentralbl Chir. 1998; 123 Suppl 5:28-32
Web of Science PubMed

 

1997

Lackner, H; Urban, C; Kerbl, R; Schwinger, W; Beham, A Noncytotoxic drug therapy in children with unresectable desmoid tumors.
Cancer. 1997; 80(2):334-340 Doi: 10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C334%3A%3AAID-CNCR22%3E3.0.CO%3B2-U (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum